Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  September 2014  »
MonTueWedThuFriSatSun
1234567
891011121314
15161718192021
22232425262728
2930 

Friends
    Links


    Entry 1 of 3111
    Last Page | Next Page
    3/16/2010 - Vertex Pharmaceuticals' telaprevir and VX-222 HCV inhibitor abstracts accepted for presentation at 45th EASL meeting
    Posted in Medical News

    Vertex Pharmaceuticals Incorporated today announced that several abstracts related to the hepatitis C virus (HCV) protease inhibitor telaprevir and the HCV polymerase inhibitor VX-222 were accepted for launch at the 45th Annual Meeting of the latin band for the Study of the Liver (EASL) in Vienna, Austria, April 14-18, 2010.

    More: - Read the rest here

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb